Guarding against vascular site infection.
Rosenthal
Kelli
K
ResourceNurse.com, Oceanside, NY, USA.
D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage; D001207:Asepsis / Q000379:methods / Q000592:standards; D019985:Benchmarking / Q000458:organization & administration; D002405:Catheterization, Central Venous / Q000009:adverse effects* / Q000451:nursing / Q000592:standards; D002406:Catheterization, Peripheral / Q000009:adverse effects* / Q000451:nursing / Q000592:standards; D002408:Catheters, Indwelling / Q000009:adverse effects* / Q000592:standards; D002487:Centers for Disease Control and Prevention, U.S.; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D002983:Clinical Competence; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003625:Data Collection; D006801:Humans; D017053:Infection Control / Q000379:methods* / Q000592:standards; D009741:Nursing Staff, Hospital / Q000193:education; D017063:Outcome Assessment, Health Care; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D017592:Skin Care / Q000379:methods / Q000451:nursing / Q000592:standards; D014481:United States / Q000453:epidemiology
D000891:Anti-Infective Agents, Local; C010882:chlorhexidine gluconate; D002710:Chlorhexidine